Metraipolis › archive › dc_2ee272f2fa58

Safety of Initiating Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure or Type 2 Diabetes and a History of Urinary Tract Infections — Europe PMC PMID:41682167

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41682167
DOI: 10.3390/healthcare14030318
License (as archived): solo-consultazione
Archived: 2026-11-06T12:02:55.881Z
SHA-256 of the archived text: 522288126a4e473994f2cf49dfc82e2fdf70b4c9079518e859d5937c76d8c46c
Stable URL of this page: https://metraipolis.com/documento/dc_2ee272f2fa58

How to cite

Safety of Initiating Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure or Type 2 Diabetes and a History of Urinary Tract Infections — Europe PMC PMID:41682167 — Europe PMC (en), https://europepmc.org/article/MED/41682167 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ee272f2fa58 (Metraipolis archive dc_2ee272f2fa58, sha256 522288126a4e473994f2cf49dfc82e2fdf70b4c9079518e859d5937c76d8c46c)

BibTeX

@misc{dc2ee272f2fa58,
  title = {Safety of Initiating Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure or Type 2 Diabetes and a History of Urinary Tract Infections — Europe PMC PMID:41682167},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41682167},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ee272f2fa58; sha256 522288126a4e473994f2cf49dfc82e2fdf70b4c9079518e859d5937c76d8c46c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41682167. Agents can read the archived copy with the MCP tool read_document.